Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, γ-IFN and IL-4) in vitro

This publication has 15 references indexed in Scilit:

• PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IS ASSOCIATED WITH REDUCED Th1 CYTOKINE RESPONSES IN THE WKY???F344 RAT MODEL
  Transplantation, 1999
• Influence of Antithrombin III on Coagulation and Inflammation in Porcine Septic Shock
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• ANTITHROMBIN III TREATMENT IMPROVES PARAMETERS OF ACUTE INFLAMMATION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT LUNG ALLOGRAFT REJECTION
  Transplantation, 1999
• The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic Implications
  Seminars in Thrombosis and Hemostasis, 1998
• Antithrombin III Prevents and Rapidly Reverses Leukocyte Recruitment in Ischemia/Reperfusion
  Circulation, 1997
• Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR
  Transplant Immunology, 1995
• Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin
  Transplant Immunology, 1994
• Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin
  Journal of Clinical Immunology, 1994
• Double-blind, Placebo-controlled Trial of Antithrombin III Concentrates in Septic Shock With Disseminated Intravascular Coagulation
  Chest, 1993
• THE ENDOTHELIAL HEPARAN SULFATE-ANTITHROMBIN III NATURAL ANTICOAGULANT PATHWAY IN NORMAL AND TRANSPLANTED HUMAN KIDNEYS
  Transplantation, 1992